Actinium Pharmaceuticals reported $-5.69M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Actinium Pharmaceuticals USD -5.69M 1.81M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Bioline Rx USD -673K 2.99M Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Pfizer USD 4.65B 71M Dec/2025